Icosavax

Share on: 
Website: Icosavax
Description: 

Develops Virus-like Particles (VLPs). VLPs enable high-density, multivalent display of antigens in a manner that closely resembles viruses, with an important difference. VLPs contain no genetic material, so they are non-infectious and can provide a safer alternative to live-attenuated or inactivated vaccines.

Career Page(s): 
Location(s): 
Seattle WA
United States